These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28516059)

  • 1. The effects of cognitive behavioral therapy and drug therapy on quality of life and symptoms of patients with irritable bowel syndrome.
    Dehkordi AH; Solati K
    J Adv Pharm Technol Res; 2017; 8(2):67-72. PubMed ID: 28516059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internet-Delivered Cognitive Behavior Therapy for Adolescents With Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bonnert M; Olén O; Lalouni M; Benninga MA; Bottai M; Engelbrektsson J; Hedman E; Lenhard F; Melin B; Simrén M; Vigerland S; Serlachius E; Ljótsson B
    Am J Gastroenterol; 2017 Jan; 112(1):152-162. PubMed ID: 27845338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive-behavioral therapy for irritable bowel syndrome: a meta-analysis.
    Li L; Xiong L; Zhang S; Yu Q; Chen M
    J Psychosom Res; 2014 Jul; 77(1):1-12. PubMed ID: 24913335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
    Lackner JM; Jaccard J; Keefer L; Brenner DM; Firth RS; Gudleski GD; Hamilton FA; Katz LA; Krasner SS; Ma CX; Radziwon CD; Sitrin MD
    Gastroenterology; 2018 Jul; 155(1):47-57. PubMed ID: 29702118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cognitive behavior therapy combined with exercise intervention on the cognitive bias and coping styles of diarrhea-predominant irritable bowel syndrome patients.
    Zhao SR; Ni XM; Zhang XA; Tian H
    World J Clin Cases; 2019 Nov; 7(21):3446-3462. PubMed ID: 31750328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Effect of Dialectical Behavior Therapy, Mindfulness Based Cognitive Therapy and Positive Psychotherapy on Perceived Stress and Quality of Life in Patients with Irritable Bowel Syndrome: a Pilot Randomized Controlled Trial.
    Mohamadi J; Ghazanfari F; Drikvand FM
    Psychiatr Q; 2019 Sep; 90(3):565-578. PubMed ID: 31152288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
    Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.
    Kennedy TM; Chalder T; McCrone P; Darnley S; Knapp M; Jones RH; Wessely S
    Health Technol Assess; 2006 Jun; 10(19):iii-iv, ix-x, 1-67. PubMed ID: 16729918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.
    Choghakhori R; Abbasnezhad A; Amani R; Alipour M
    Dig Dis Sci; 2017 Jun; 62(6):1550-1560. PubMed ID: 28374085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cognitive behavioral therapy in female nursing students with irritable bowel syndrome: a randomized trial.
    Jang AL; Hwang SK; Kim DU
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):918-26. PubMed ID: 24999797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea.
    Abel JL; Carson RT; Andrae DA
    Qual Life Res; 2019 Feb; 28(2):369-377. PubMed ID: 30267294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea.
    Zhu L; Huang D; Shi L; Liang L; Xu T; Chang M; Chen W; Wu D; Zhang F; Fang X
    Health Qual Life Outcomes; 2015 Apr; 13():49. PubMed ID: 25925746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial.
    Everitt HA; Landau S; O'Reilly G; Sibelli A; Hughes S; Windgassen S; Holland R; Little P; McCrone P; Bishop FL; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):863-872. PubMed ID: 31492643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effect of herb-separated moxibustion at Jinsuo (GV 8)-eight-diagram points on diarrhea-type irritable bowel syndrome of liver stagnation and spleen deficiency].
    Hao LJ; Shi ZM
    Zhongguo Zhen Jiu; 2020 Jul; 40(7):702-6. PubMed ID: 32648391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Psychotherapy for Refractory Irritable Bowel Syndrome: A Systematic Review.
    Slouha E; Mohamed A; Patel B; Razeq Z; Clunes LA; Kollias TF
    Cureus; 2024 Feb; 16(2):e54138. PubMed ID: 38487115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive behavioral therapy with interoceptive exposure and complementary video materials for irritable bowel syndrome (IBS): protocol for a multicenter randomized controlled trial in Japan.
    Kawanishi H; Sekiguchi A; Funaba M; Fujii Y; Yoshiuchi K; Kikuchi H; Kawai K; Maruo K; Sugawara N; Hatano K; Shoji T; Yamazaki T; Toda K; Murakami M; Shoji M; Ohara C; Tomita Y; Fukudo S; Ando T
    Biopsychosoc Med; 2019; 13():14. PubMed ID: 31178921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up.
    Lackner JM; Jaccard J; Radziwon CD; Firth RS; Gudleski GD; Hamilton F; Katz LA; Keefer L; Krasner SS; Ma CX; Sitrin MD; Brenner DM
    Am J Gastroenterol; 2019 Feb; 114(2):330-338. PubMed ID: 30429592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
    Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
    Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.
    Abbasnezhad A; Amani R; Hajiani E; Alavinejad P; Cheraghian B; Ghadiri A
    Neurogastroenterol Motil; 2016 Oct; 28(10):1533-44. PubMed ID: 27154424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.